Xiaosong Ben - Concepedia

Author

Xiaosong Ben

Guangdong Academy of Medical Sciences ORCID

Also Known As

Ben, Xiaosong, Q. Wang, W. Qun, X Ben, X-S. Ben, X. Ben, X.-S. Ben, Xiao-Song Ben, Xiao-song Ben, Xiaosong Ben

Publications

906

Citations

H-Index

Concepts

All Affiliations

Guangdong Academy of Medical Sciences Guangdong Provincial People's Hospital Sun Yat-sen University Southern Medical University Jinan University

About

Xiaosong Ben is an author at Guangdong Academy of Medical Sciences specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	137
2	Public Health	1	1	32
3	Cell Biology	1	1	35
4	Epidemiology	1	1	32
5	Global Health	1	1	32

Xiaosong Ben

Publications

778

Citations

H-Index

Page 1

	Year	Citations
Assessing the impact of coordinated COVID-19 exit strategies across Europe Nick Ruktanonchai, Jessica Floyd, Shengjie Lai, Science	2020	228
Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study Guibin Qiao, Weitao Zhuang, Bo Dong, BMC Medicine	2021	56
Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients Mian Xie, Xiaojun Wu, Fang Wang, Journal of Thoracic Oncology Lymphoid NeoplasiaCancer-associated VirusMedicineMalignant Blood DisorderImmunology	2017	52
Surgical correction of 639 pectus excavatum cases via the Nuss procedure. Dong-kun Zhang, Jiming Tang, Xiaosong Ben, PubMed	2015	49
Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma M.-T. Wang, G. Chen, S.-J. An, Diseases of the Esophagus	2011	39
TCF19 contributes to cell proliferation of non‐small cell lung cancer by inhibiting FOXO1 Zi‐Hao Zhou, Gang Chen, Cheng Deng, Cell Biology International Transcription Factor 19MedicinePathologyCancer Cell BiologyImmune Surveillance	2019	35
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study Si‐Yang Liu, Song Dong, Xue‐Ning Yang, Signal Transduction and Targeted Therapy	2023	35
Assessing the impact of coordinated COVID-19 exit strategies across Europe Nick Ruktanonchai, Jessica Floyd, Shengjie Lai, Epidemiological DynamicCovid-19 EpidemiologyCoordinated Exit StrategiesPandemic ManagementCovid-19	2020	32
Association of acrylamide hemoglobin biomarkers with chronic obstructive pulmonary disease in the general population in the US: NHANES 2013–2016 Shan Liu, Xiaosong Ben, Huanzhu Liang, Food & Function	2021	29
Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro) Shujie Huang, Hansheng Wu, Chao Cheng, Frontiers in Immunology	2022	28

Page 1